Abstract
Synucleins are emerging as central players in the formation of pathologically insoluble deposits characteristic of neurodegenerative diseases. However, synuclein γ (SNCG), previously identified as a breast cancer specific gene (BCSG1), is also highly associated with breast cancer progression. Using transgenic mouse model, we demonstrated a role of SNCG in induction of highly proliferative pregnancy-like phenotype of mammary epithelial cells and branching morphology. SNCG participated in the heat shock protein-based multiprotein chaperone complex for steroid receptor signaling. Expression of SNCG in mammary epithelium resulted in a significant stimulation of ERα transcriptional activity. SNCG-induced mammary gland proliferation can be effectively blocked by antiestrogen and ovariectomy, indicating that the induced proliferation is mediated by ERα signaling and requires estrogen stimulation. These data indicate the chaperone activity of SNCG on stimulation of steroid receptor signaling in mammary gland and, thus induces extensive mammary gland proliferation and contributes to the hormonal impact on mammary tumorigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout









Similar content being viewed by others
Abbreviations
- AD:
-
Alzheimer's disease
- BCSG1:
-
breast cancer specific gene 1
- Cat-D:
-
Cathepsin D
- ERα:
-
estrogen receptor α
- Hsp:
-
heat shock protein
- PD:
-
Parkinson's disease
- PR:
-
progesterone receptor
- SNCA:
-
α synuclein
- SNCB:
-
β synuclein
- SNCG:
-
γ synuclein
References
Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ, Godwin AK . (2000). Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 88: 2154–2163.
Clayton DF, George JM . (1998). The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 21: 249–254.
Duda JE, Lee VM, Trojanowski JQ . (2000). Neuropathology of synuclein aggregates. J Neurosci Res 61: 121–127.
Galvin JE, Uryu K, Lee VM, Trojanowski JQ . (1999). Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta- and gamma-synuclein. Proc Natl Acad Sci USA 96: 13450–13455.
Geisler J . (2003). Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators. J Steroid Biochem Mol Biol 86: 245–253.
Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J . (2003a). Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res 63: 664–673.
Gupta A, Inaba S, Wong OK, Fang G, Liu J . (2003b). Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1. Oncogene 22: 7593–7599.
Inaba S, Li C, Shi YE, Song DQ, Jiang JD, Liu J . (2005). Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res Treat 94: 25–35.
Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G et al. (1997). Identification of a breast cancer-specific gene, BCSG1 by direct differential cDNA sequencing. Cancer Res 57: 759–764.
Jia T, Liu YE, Liu J, Shi YE . (1999). Stimulation of breast cancer invasion and metastasis by synuclein gamma. Cancer Res 59: 742–747.
Jiang Y, Liu YE, Goldberg ID, Shi YE . (2004). synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor α signaling and mammary tumorigenesis. Cancer Res 64: 4539–4546.
Jiang Y, Liu YE, Lu A, Gupta A, Goldberg ID, Liu J et al. (2003). Stimulation of estrogen receptor signaling by gamma synuclein. Cancer Res 63: 3899–3903.
Lavedan C, Leroy E, Dehejia A, Buchholtz S, Dutra A, Nussbaum RL et al. (1998). Identification, localization and characterization of the human gamma-synuclein gene. Hum Genet 103: 106–112.
Liu J, Spence MJ, Zhang YL, Jiang Y, Liu YE, Shi YE . (2000). Transcriptional suppression of synuclein gamma (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M. Breast Cancer Res Treat 62: 99–107.
Liu H, Liu W, Wu Y, Zhou Y, Xue R, Luo C et al. (2005). Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res 65: 7635–7643.
Lu A, Gupta A, Li C, Ahlborn TE, Ma Y, Shi YE et al. (2001). Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences. Oncogene 20: 5173–5185.
Lu A, Zhang F, Gupta A, Liu L . (2000). Blockade of AP1 transactivation abrogates the abnormal expression of breast cancer-specific gene 1 in breast cancer cells. J Biol Chem 277: 31364–31372.
Ninkina NN, Alimova-Kost MV, Paterson JW, Delaney L, Cohen BB, Imreh S et al. (1998). Organization, expression and polymorphism of the human persyn gene. Hum Mol Genet 7: 1417–1424.
Pan ZZ, Bruening W, Giasson BL, Lee VM, Godwin AK . (2002). Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways. J Biol Chem 277: 35050–35060.
Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045–2047.
Pratt WB, Toft DO . (1997). Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18: 306–360.
Shi YE, Ni J, Xiao G, Liu YE, Fuchs A, Yu G et al. (1997). Antitumor activity of the novel human breast cancer growth inhibitior, mammary-derived growth inhibitor-related gene, MRG. Cancer Res 57: 3084–3091.
Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M . (1997). Alpha-synuclein in Lewy bodies. Nature 388: 839–840.
Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E . (1998). Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am J Pathol 152: 367–372.
Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M et al. (1993). Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90: 11282–11286.
Wang M, Liu YE, Goldberg ID, Shi YE . (2003). Induction of Mammary Gland Differentiation in Transgenic Mice by the Fatty Acid Binding Protein MRG. J Biol Chem 278: 47319–47325.
Wang M, Liu YE, Ni J, Aygun B, Goldberg ID, Shi YE . (2000). Induction of mammary differentiation by MRG that interacts with ω-3 fatty acid on growth inhibition of breast cancer cells. Cancer Res 60: 6482–6487.
Wu K, Weng Z, Tao Q, Lin G, Wu X, Qian H et al. (2003). Stage-specific expression of breast cancer-specific gene gamma synuclein. Cancer Epidemiol Biomarkers Prev 12: 920–925.
Wu K, Quan Z, Weng Z, Li F, Zhang Y, Yao X et al. (2006). Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis. Breast Cancer Res Treat 2006 July 4; [E-pub ahead of print].
Xiao G, Liu YE, Gentz R, Sang QA, Ni J, Goldberg ID et al. (1999). Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells. Proc Natl Acad Sci USA 96: 3700–3705.
Yoshimoto M, Iwai A, Kang D, Otero DA, Xia Y, Saitoh T . (1995). NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation. Proc Natl Acad Sci USA 92: 9141–9145.
Acknowledgements
This study was supported in part by grant (99-028-01-CCE) from American cancer Society, grants (W81XWH-04-1-0569) from the United States Army Medical Research and Development Command.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Y., Pu, W., Jiang, Y. et al. Chaperoning of estrogen receptor and induction of mammary gland proliferation by neuronal protein synuclein gamma. Oncogene 26, 2115–2125 (2007). https://doi.org/10.1038/sj.onc.1210000
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.onc.1210000
Keywords
This article is cited by
-
Synuclein γ protects Akt and mTOR and renders tumor resistance to Hsp90 disruption
Oncogene (2015)
-
Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer
Oncogene (2010)
-
Desipramine Modulation of α-, γ-Synuclein, and the Norepinephrine Transporter in an Animal Model of Depression
Neuropsychopharmacology (2009)
-
A candidate molecular signature associated with tamoxifen failure in primary breast cancer
Breast Cancer Research (2008)


